Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,817,256 papers from all fields of science
Search
Sign In
Create Free Account
golimumab
A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
0.5 ML golimumab 100 MG/ML Auto-Injector [Simponi]
0.5 ML golimumab 100 MG/ML Prefilled Syringe
1 ML golimumab 100 MG/ML Auto-Injector
1 ML golimumab 100 MG/ML Auto-Injector [Simponi]
Expand
Broader (1)
Monoclonal Antibodies
Narrower (1)
Simponi
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Alopecia Areata and Scarring Alopecia Presenting During Golimumab Therapy for Ankylosing Spondylitis
Melissa M. Helm
,
S. Haddad
2018
Corpus ID: 79935264
Golimumab is a human monoclonal antibody useful in the treatment of a wide variety of inflammatory conditions including…
Expand
2016
2016
Managing the Patient Being Treated with Biologic Agents for Rheumatic Disease: Pearls for the General Internist
Alfred A. Cividino Md Frcpc Facr
2016
Corpus ID: 75333742
Rheumatoid arthritis (RA) is a chronic polyarticular disease with systemic consequences leading to impairment and disability…
Expand
2015
2015
Budget Impact Analysis of Tofacitinib for treatment of Rheumatoid Arthritis
R. Bhattacharya
,
Khalid M. Kamal
2015
Corpus ID: 55636707
Objective: Tofacitinib is a novel oral biologic that has been approved for treating adults with Rheumatoid arthritis (RA) having…
Expand
2015
2015
Current treatment approaches in patients with ankylosing spondylitis
B. Elbey
2015
Corpus ID: 74762278
Ankylosing spondylitis (AS) is a chronic, inflammatory, rheumatic disease that mainly affects sacroiliac joints and spine. AS…
Expand
2014
2014
Role of golimumab for the treatment of rheumatoid arthritis
G. Tran
,
P. Emery
2014
Corpus ID: 44831059
Golimumab, a fully humanized anti-TNFα monoclonal antibody, is a recent addition to this class of biological agents used in the…
Expand
2013
2013
Golimumab For Ulcerative Colitis
D. Aschenbrenner
2013
Corpus ID: 71700922
* Golimumab, a monoclonal antibody, has been approved to treat moderate-to-severe ulcerative colitis in adults who've been…
Expand
Review
2012
Review
2012
НОВЫЙ БЛОКАТОР ФНО α — ГОЛИМУМАБ. ОБЗОР РЕЗУЛЬТАТОВ ИССЛЕДОВАНИЙ ПО ОЦЕНКЕ ЭФФЕКТИВНОСТИ И БЕЗОПАСНОСТИ
Рина Валериановна Денисова
,
Екатерина Иосифовна Алексеева
2012
Corpus ID: 139091592
The article represents the results of efficacy and safety evaluation of the human monoclonal antibodies — golimumab, according to…
Expand
2009
2009
Golimumab: a new anti-TNF agent on the horizon for inflammatory arthritis
S. Bhagat
,
B. Dasgupta
,
Mahboob Rahman
2009
Corpus ID: 21864791
Rheumatoid arthritis (RA), psoriatic arthritis, and ankylosing spondylitis are highly prevalent inflammatory arthritides. Various…
Expand
2009
2009
The of Rheumatology Clinical Trials of Golimumab in Rheumatoid Arthritis Randomized Sedimentation Rate and C-Reactive Protein Measurements from Which Measure of Inflammation to Use? A Comparison of…
C. Crowson
,
Mahboob Rahman
,
E. Matteson
2009
Corpus ID: 207786790
. Objective. To assess clinical utility of measurements of C-reactive protein (CRP) versus Westergren erythrocyte sedimentation…
Expand
2008
2008
Case Study: Immunogenicity of Anti-TNF Antibodies
K. Bendtzen
2008
Corpus ID: 68641718
Anti-tumor necrosis factor (TNF) therapy has become an important alternative in the management of several chronic…
Expand